Human medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of authorisation: 16/02/2024, Revision: 1, Status: Authorised

Mysimba Article-20 procedure - Timetable for the procedure

Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 32, Status: Authorised

Organisation chart: Information Management

Human medicines European public assessment report (EPAR): Azopt, brinzolamide, Date of authorisation: 09/03/2000, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Deferasirox Accord, deferasirox, Date of authorisation: 09/01/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Apremilast Viatris, apremilast, Status: Application withdrawn

Annex to interim measures regarding notification of pharmacovigilance alerts by marketing authorisation holders under Regulation (EU) 2019/6: contact points

IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants